Acute febrile illness in Kenya: Clinical characteristics and pathogens detected among patients hospitalized with fever, 2017-2019.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 14 02 2024
accepted: 04 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

Acute febrile illness (AFI) is a common reason for healthcare seeking and hospitalization in Sub-Saharan Africa and is often presumed to be malaria. However, a broad range of pathogens cause fever, and more comprehensive data on AFI etiology can improve clinical management, prevent unnecessary prescriptions, and guide public health interventions. We conducted surveillance for AFI (temperature ≥38.0°C <14 days duration) among hospitalized patients of all ages at four sites in Kenya (Nairobi, Mombasa, Kakamega, and Kakuma). For cases of undifferentiated fever (UF), defined as AFI without diarrhea (≥3 loose stools in 24 hours) or lower respiratory tract symptoms (cough/difficulty breathing plus oxygen saturation <90% or [in children <5 years] chest indrawing), we tested venous blood with real-time PCR-based TaqMan array cards (TAC) for 17 viral, 8 bacterial, and 3 protozoal fever-causing pathogens. From June 2017 to March 2019, we enrolled 3,232 AFI cases; 2,529 (78.2%) were aged <5 years. Among 3,021 with outcome data, 131 (4.3%) cases died while in hospital, including 106/2,369 (4.5%) among those <5 years. Among 1,735 (53.7%) UF cases, blood was collected from 1,340 (77.2%) of which 1,314 (98.1%) were tested by TAC; 715 (54.4%) had no pathogens detected, including 147/196 (75.0%) of those aged <12 months. The most common pathogen detected was Plasmodium, as a single pathogen in 471 (35.8%) cases and in combination with other pathogens in 38 (2.9%). HIV was detected in 51 (3.8%) UF cases tested by TAC and was most common in adults (25/236 [10.6%] ages 18-49, 4/40 [10.0%] ages ≥50 years). Chikungunya virus was found in 30 (2.3%) UF cases, detected only in the Mombasa site. Malaria prevention and control efforts are critical for reducing the burden of AFI, and improved diagnostic testing is needed to provide better insight into non-malarial causes of fever. The high case fatality of AFI underscores the need to optimize diagnosis and appropriate management of AFI to the local epidemiology.

Identifiants

pubmed: 39088453
doi: 10.1371/journal.pone.0305700
pii: PONE-D-24-01611
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0305700

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Jennifer R Verani (JR)

Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.

Eric Ng' Eno (EN)

Washington State University Global Health, Nairobi, Kenya.

Elizabeth A Hunsperger (EA)

Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.

Peninah Munyua (P)

Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.

Eric Osoro (E)

Washington State University Global Health, Nairobi, Kenya.

Doris Marwanga (D)

Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

Godfrey Bigogo (G)

Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

Derrick Amon (D)

Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

Melvin Ochieng (M)

Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

Paul Etau (P)

Kenyatta National Hospital, Nairobi, Kenya.

Victor Bandika (V)

Coast General Provincial Hospital, Mombasa, Kenya.

Victor Zimbulu (V)

Kakamega County Referral Hospital, Kakamega, Kenya.

John Kiogora (J)

International Rescue Committee, Nairobi, Kenya.

John Wagacha Burton (JW)

United Nations High Commissioner for Refugees, Nairobi, Kenya.

Emmanuel Okunga (E)

Disease Surveillance and Response Unit, Ministry of Health, Nairobi, Kenya.

Aaron M Samuels (AM)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya and Atlanta, Georgia, United States of America.

Kariuki Njenga (K)

Washington State University Global Health, Nairobi, Kenya.

Joel M Montgomery (JM)

Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH